Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics NeoLab Assays

NeoGenomics launched its first 12 NeoLab liquid biopsy-based assays. The assays are based on next-generation sequencing and other molecular technologies and use cell-free circulating DNA and RNA found in blood plasma to identify molecular abnormalities in the bone marrow without the need for a bone marrow biopsy. The new assays include MDS/CMML profiling, AML profiling, FLT3 mutation analysis, NPM1 mutation analysis, IDH1/IDH2 mutation analysis, NRAS mutation analysis, KRAS mutation analysis, and translocations of PML-RARA, RUNX1-RUNX1T1, and Inv16.